- Home
- GPCR vs LENZ Comparison
GPCR vs LENZ Comparison
Compare GPCR & LENZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GPCR
- LENZ
- Stock Information
- Founded
- GPCR 2016
- LENZ 2019
- Country
- GPCR United States
- LENZ United States
- Employees
- GPCR N/A
- LENZ N/A
- Industry
- GPCR
- LENZ Medicinal Chemicals and Botanical Products
- Sector
- GPCR
- LENZ Health Care
- Exchange
- GPCR Nasdaq
- LENZ Nasdaq
- Market Cap
- GPCR 1.2B
- LENZ 1.2B
- IPO Year
- GPCR 2023
- LENZ 2021
- Fundamental
- Price
- GPCR $27.28
- LENZ $48.74
- Analyst Decision
- GPCR Strong Buy
- LENZ Strong Buy
- Analyst Count
- GPCR 8
- LENZ 4
- Target Price
- GPCR $69.57
- LENZ $49.75
- AVG Volume (30 Days)
- GPCR 1.0M
- LENZ 406.2K
- Earning Date
- GPCR 11-12-2025
- LENZ 11-05-2025
- Dividend Yield
- GPCR N/A
- LENZ N/A
- EPS Growth
- GPCR N/A
- LENZ N/A
- EPS
- GPCR N/A
- LENZ N/A
- Revenue
- GPCR N/A
- LENZ $5,000,000.00
- Revenue This Year
- GPCR N/A
- LENZ N/A
- Revenue Next Year
- GPCR N/A
- LENZ $285.73
- P/E Ratio
- GPCR N/A
- LENZ N/A
- Revenue Growth
- GPCR N/A
- LENZ N/A
- 52 Week Low
- GPCR $13.22
- LENZ $16.54
- 52 Week High
- GPCR $43.46
- LENZ $50.40
- Technical
- Relative Strength Index (RSI)
- GPCR 68.40
- LENZ 70.59
- Support Level
- GPCR $25.65
- LENZ $39.51
- Resistance Level
- GPCR $28.12
- LENZ $50.40
- Average True Range (ATR)
- GPCR 1.60
- LENZ 2.17
- MACD
- GPCR 0.28
- LENZ 0.66
- Stochastic Oscillator
- GPCR 89.60
- LENZ 84.76
About GPCR Structure Therapeutics Inc.
Structure Therapeutics Inc is a clinical-stage biopharmaceutical company developing novel oral small-molecule therapeutics to treat a wide range of chronic diseases with unmet medical needs. Its differentiated technology platform leverages both structure-based drug discovery and expertise in computational chemistry to discover and develop small molecule therapeutics against G-protein coupled receptors (GPCRs). The group operates and manages its business as one reportable and operating segment, which is the business of research and development of medicines that target chronic diseases with unmet medical needs.
About LENZ LENZ Therapeutics Inc.
LENZ Therapeutics Inc is a late-stage biopharmaceutical company focused on developing and commercializing therapies to improve vision and developing ophthalmic pharmaceutical products.. Its initial focus is the treatment of presbyopia, the inevitable loss of near vision that impacts the daily lives of nearly all people over 45.